Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.

Haihui JiangWei ZengXiaohui RenYong CuiMingxiao LiKaiyuan YangMohammad ElbaroodySong Lin

Published in: Journal of neuro-oncology (2019)

This retrospective study highlights that super-early initiation of TMZ in newly diagnosed GBM may confer to survival benefit, especially for those without GTR.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis